Protein Kinase C δ Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest*

  1. Ademi E. Santiago-Walker,1,
  2. Aphrothiti J. Fikaris,
  3. Gary D. Kao§,
  4. Eric J. Brown,
  5. Marcelo G. Kazanietz and
  6. Judy L. Meinkoth,2
  1. Departments of Pharmacology, §Radiation Oncology, and Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6061
  1. 2 To whom correspondence should be addressed: Dept. of Pharmacology, University ofPennsylvania School of Medicine, Rm. 1251 BRB II/III, 421 Curie Boulevard, Philadelphia, PA 19104-6061. Tel.: 215-898-1909; Fax: 215-746-8941; E-mail: meinkoth{at}pharm.med.upenn.edu.

Abstract

Overexpression of protein kinase C δ (PKCδ) stimulates apoptosis in a wide variety of cell types through a mechanism that is incompletely understood. PKCδ-deficient cells are impaired in their response to DNA damage-induced apoptosis, suggesting that PKCδ is required to mount an appropriate apoptotic response under conditions of stress. The mechanism through which it does so remains elusive. In addition to effects on cell survival, PKCδ elicits pleiotropic effects on cellular proliferation. We now provide the first evidence that the ability of PKCδ to stimulate apoptosis is intimately linked to its ability to stimulate G1 phase cell cycle progression. Using an adenoviral-based expression system to express PKCα,-δ, and -ϵ in epithelial cells, we demonstrate that a modest increase in PKCδ activity selectively stimulates quiescent cells to initiate G1 phase cell cycle progression. Rather than completing the cell cycle, PKCδ-infected cells arrest in S phase, an event that triggers caspase-dependent apoptotic cell death. Apoptosis was preceded by the activation of cell cycle checkpoints, culminating in the phosphorylation of Chk-1 and p53. Strikingly, blockade of S phase entry using the phosphatidylinositol 3-kinase inhibitor LY294002 prevented checkpoint activation and apoptosis. In contrast, inhibitors of mitogen-activated protein kinase cascades failed to prevent apoptosis. These findings demonstrate that the biological effects of PKCδ can be extended to include positive regulation of G1 phase cell cycle progression. Importantly, they reveal the existence of a novel, cell cycle-dependent mechanism through which PKCδ stimulates cell death.

Footnotes

  • 3 The abbreviations used are: PKC, protein kinase C; BrdUrd, bromodeoxyuridine; TPA,12-O-tetradecanoylphorbol 13-acetate; p, particles; DAPI, 4′,6-diamidino-2-phenylindole; JNK, c-Jun NH2-terminal kinase; QVD, Q-VD-OPh; ATR, ATM and Rad3-related; DNA-PK, DNA-dependent protein kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK/extracellular signal-regulated kinase kinase; PI3K, phosphatidylinositol 3-kinase; FACS, fluorescence-activated cell sorting.

  • * This work was supported by Public Health Service Grant DK-45696 from NIDDK,National Institutes of Health (NIH) and Grant CA-109543 from NCI, NIH (to J. L. M.) and by Grants CA-89202 and CA-92537 from NCI, NIH (to M. G. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 Supported by a minority training grant supplement to Grant DK-45696.

    • Received April 22, 2005.
    • Revision received July 25, 2005.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement